Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the Listing Regulations, we hereby inform you that a teleconference has been scheduled with Analysts on Wednesday, August 5, 2020, at 4.00 p.m to discuss the Company's financial performance for the quarter ended June 30, 2020. Please note that the scheduled teleconference is subject to change on account of exigencies on the part of the Analyst/Institutional Investor or the Company. This schedule of the teleconference shall also be displayed on the website of the Company - www.pfizerindia.com in compliance with the Regulation 46 of the Listing Regulations. Please take the above on record
04-08-2020
Bigul

Pfizer, BioNTech to supply 120 mn doses of coronavirus vaccine to Japan

 BioNTech and Pfizer on Monday began a large, late-stage trial of their vaccine candidate to demonstrate its efficacy
31-07-2020
Bigul

Coronavirus vaccine update: Moderna plans to price vaccine at $50-$60 per course

 Coronavirus vaccine update: Moderna aims to sell its coronavirus vaccine at a proposed price of $50 to $60 per course, higher than other firms such as Pfizer and BioNTech, if it's successfully developed
29-07-2020
Bigul

Coronavirus vaccine: Pfizer to charge other developed nations at par with US

 Pfizer is one of many companies racing to bring COVID-19 vaccines to market, seen as essential to ending a pandemic that has claimed more than 655,000 lives globally
29-07-2020
Bigul

PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pfizer Limited - Press Release
27-07-2020
Bigul

PFIZER LTD. - 500680 - Unaudited Financial Results For The Quarter Ended June 30, 2020.

 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter ended June 30, 2020, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 3:30 p.m. and concluded at 5:45 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results. Please take the above on record.
27-07-2020

Chinese COVID-19 vaccine candidate shows promise in animal tests

 ARCoV is a messenger RNA vaccine which uses technology similar to candidates being developed by Moderna and BioNtech and Pfizer. It is the second potential COVID-19 vaccine that China's military-backed research unit has moved into clinical trials.
24-07-2020
Bigul

More shots at Covid, but a long journey ahead

 Leading pharma firms in race will face challenges on trials, distribution; AstraZeneca-Oxford, BioNTech-Pfizer have put out vaccine trial data
21-07-2020
Bigul

Coronavirus vaccine update: Oxford, Pfizer vaccines safe, give immunity

 There are 23 coronavirus vaccine candidates in human trials, including Moderna, AstraZeneca Plc, BioNTech, Novavax, Sinovac, CanSino Biologics and Inovio. Catch latest updates on Covid-19 vaccine
21-07-2020
Bigul

Coronavirus vaccine: COVAXIN trials begin; Serum Institute of India plans millions of doses in 3 months

 Coronavirus vaccine news update: Goldman Sachs believes that a coronavirus vaccine could be approved by the end of the year. It predicts Moderna and Pfizer's candidates to be the first ones to pass regulatory hurdles
18-07-2020
Next Page
Close

Let's Open Free Demat Account